Biotest AG: Biotest Pharmaceuticals Honoured with the 2013 Greater Miami Chamber of Commerce International Business Leadership Award for 'Business Expansion'
Biotest AG / Key word(s): Miscellaneous / Biotest Pharmaceuticals Honoured with the 2013 Greater Miami Chamber of Commerce International Business Leadership Award for 'Business Expansion' Boca Raton, FL, US/ Dreieich, Germany, November 20, 2013 - Biotest Pharmaceuticals Corporation (BPC), a wholly owned US subsidiary of Biotest AG, (Dreieich Germany), announced yesterday that it has been awarded the 2013 International Business Leadership Award for 'Business Expansion' from the Greater Miami Chamber of Commerce. This award recognizes companies that uniquely focus on retaining and growing existing international business relationships and whose activities provide a significant impact on the Florida economy. Disclaimer This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and assets position of Biotest AG and its subsidiaries. These statements are based on current plans, estimates, forecasts and expectations of the company and are thus subject to risks and elements of uncertainty that could result in significant deviation of actual developments from expected developments. The forward-looking statements are only valid at the time of publication. Biotest does not intend to update the forward-looking statements and assumes no obligation to do so. About Biotest Biotest AG, Landsteinerstr. 5, 63303 Dreieich, www.biotest.de Securities' ID No., ISIN ordinary shares: 522720, DE0005227201 End of Corporate News 20.11.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.medientreff.de and www.dgap.de |
Language: | English | |
Company: | Biotest AG | |
Landsteinerstraße 5 | ||
63303 Dreieich | ||
Germany | ||
Phone: | 0 61 03 - 8 01-0 | |
Fax: | 0 61 03 - 8 01-150 | |
E-mail: | investor_relations@biotest.de | |
Internet: | http://www.biotest.de | |
ISIN: | DE0005227235, DE0005227201 | |
WKN: | 522723, 522720 | |
Indices: | SDAX | |
Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart | |
End of News | DGAP News-Service |
240770 20.11.2013 |